<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass - Lewicki, M - 2015 | Cochrane Library</title> <meta content="HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass - Lewicki, M - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010480.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass - Lewicki, M - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010480.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010480.pub2" name="dc.identifier" scheme="DOI"/> <meta content="HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass" name="citation_title"/> <meta content="Michelle Lewicki" name="citation_author"/> <meta content="michelle.lewicki@monash.edu" name="citation_author_email"/> <meta content="Irene Ng" name="citation_author"/> <meta content="Antoine G Schneider" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD010480.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/03/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010480.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010480.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010480.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acute Kidney Injury [*prevention &amp; control, therapy]; Atorvastatin; Cardiac Surgical Procedures; Cardiopulmonary Bypass [*adverse effects]; Coronary Artery Bypass [*adverse effects]; Creatinine [blood]; Fluorobenzenes [therapeutic use]; Heptanoic Acids [*therapeutic use]; Hydroxymethylglutaryl‐CoA Reductase Inhibitors [*therapeutic use]; Length of Stay; Pyrimidines [therapeutic use]; Pyrroles [*therapeutic use]; Randomized Controlled Trials as Topic; Renal Replacement Therapy; Rosuvastatin Calcium; Simvastatin [therapeutic use]; Sulfonamides [therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010480.pub2&amp;doi=10.1002/14651858.CD010480.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="BqmVIxTs";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010480\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010480\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010480.pub2",title:"HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass",firstPublishedDate:"Mar 11, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010480.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010480.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010480.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010480.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010480.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010480.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010480.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010480.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010480.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010480.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1970 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010480.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0090"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0061"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-sec-0084"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/appendices#CD010480-sec-0095"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/table_n/CD010480StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/table_n/CD010480StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#CD010480-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Michelle Lewicki</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#CD010480-cr-0003">Irene Ng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information#CD010480-cr-0004">Antoine G Schneider</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information/en#CD010480-sec-0099">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 March 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010480.pub2">https://doi.org/10.1002/14651858.CD010480.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010480-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010480-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010480-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010480-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010480-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010480-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010480-abs-0001" lang="en"> <section id="CD010480-sec-0001"> <h3 class="title" id="CD010480-sec-0001">Background</h3> <p>Acute kidney injury (AKI) is common in patients undergoing cardiac surgery among whom it is associated with poor outcomes, prolonged hospital stays and increased mortality. Statin drugs can produce more than one effect independent of their lipid lowering effect, and may improve kidney injury through inhibition of postoperative inflammatory responses. </p> </section> <section id="CD010480-sec-0002"> <h3 class="title" id="CD010480-sec-0002">Objectives</h3> <p>This review aimed to look at the evidence supporting the benefits of perioperative statins for AKI prevention in hospitalised adults after surgery who require cardiac bypass. The main objectives were to 1) determine whether use of statins was associated with preventing AKI development; 2) determine whether use of statins was associated with reductions in in‐hospital mortality; 3) determine whether use of statins was associated with reduced need for RRT; and 4) determine any adverse effects associated with the use of statins. </p> </section> <section id="CD010480-sec-0003"> <h3 class="title" id="CD010480-sec-0003">Search methods</h3> <p>We searched the Cochrane Renal Group's Specialised Register to 13 January 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. </p> </section> <section id="CD010480-sec-0004"> <h3 class="title" id="CD010480-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) that compared administration of statin therapy with placebo or standard clinical care in adult patients undergoing surgery requiring cardiopulmonary bypass and reporting AKI, serum creatinine (SCr) or need for renal replacement therapy (RRT) as an outcome were eligible for inclusion. All forms and dosages of statins in conjunction with any duration of pre‐operative therapy were considered for inclusion in this review. </p> </section> <section id="CD010480-sec-0005"> <h3 class="title" id="CD010480-sec-0005">Data collection and analysis</h3> <p>All authors extracted data independently and assessments were cross‐checked by a second author. Likewise, assessment of study risk of bias was initially conducted by one author and then by a second author to ensure accuracy. Disagreements were arbitrated among authors until consensus was reached. Authors from two of the included studies provided additional data surrounding post‐operative SCr as well as need for RRT. Meta‐analyses were used to assess the outcomes of AKI, SCr and mortality rate. Data for the outcomes of RRT and adverse effects were not pooled. Adverse effects taken into account were those reported by the authors of included studies. </p> </section> <section id="CD010480-sec-0006"> <h3 class="title" id="CD010480-sec-0006">Main results</h3> <p>We included seven studies (662 participants) in this review. All except one study was assessed as being at high risk of bias. Three studies assessed atorvastatin, three assessed simvastatin and one investigated rosuvastatin. All studies collected data during the immediate perioperative period only; data collection to hospital discharge and postoperative biochemical data collection ranged from 24 hours to 7 days. Overall, pre‐operative statin treatment was not associated with a reduction in postoperative AKI, need for RRT, or mortality. Only two studies (195 participants) reported postoperative SCr level. In those studies, patients allocated to receive statins had lower postoperative SCr concentrations compared with those allocated to no drug treatment/placebo (MD 21.2 µmol/L, 95% CI ‐31.1 to ‐11.1). Adverse effects were adequately reported in only one study; no difference was found between the statin group compared to placebo. </p> </section> <section id="CD010480-sec-0007"> <h3 class="title" id="CD010480-sec-0007">Authors' conclusions</h3> <p>Analysis of currently available data did not suggest that preoperative statin use is associated with decreased incidence of AKI in adults after surgery who required cardiac bypass. Although a significant reduction in SCr was seen postoperatively in people treated with statins, this result was driven by results from a single study, where SCr was considered as a secondary outcome. The results of the meta‐analysis should be interpreted with caution; few studies were included in subgroup analyses, and significant differences in methodology exist among the included studies. Large high quality RCTs are required to establish the safety and efficacy of statins to prevent AKI after cardiac surgery. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010480-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010480-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010480-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010480-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010480-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010480-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010480-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010480-abs-0004" lang="en"> <h3>Do statins prevent kidney failure in adults after surgery where cardiac bypass is used? </h3> <p>Heart surgeries are performed routinely in developed countries and their safety has increased significantly. However, heart surgery is still associated with complications. Of those, kidney failure is of great importance; and patients whose kidneys fail after a heart operation are more likely to have other health problems. Preventing kidney failure after heart surgery is therefore a major health issue. </p> <p>Cardiac bypass, which replaces heart and lung functions by diverting blood from major vessels to a machine during surgery, is required for most major heart operations. Cardiac bypass is known to release molecules that cause inflammation into the blood. In susceptible people, these molecules could cause kidney failure. Statins are drugs used to decrease fatty acid (lipid) levels in the blood and help prevent cardiac and vascular disease. Statins also seem to decrease the general level of inflammation in the blood. Although animal studies have suggested that statins could help to prevent kidney failure after heart surgery, they can also cause adverse effects. More evidence is required before statins can be routinely used. </p> <p>This review aims to evaluate evidence on the use of statins at the time of heart surgery to investigate if use can help to prevent kidney failure and how well statins are tolerated among patients. We searched the literature to January 2015 and included seven studies that involved a total of 662 participants to inform our assessment. In these studies, patients planned for heart surgery received statins or placebo (or no treatment at all). Five studies (467 participants) reported rates of kidney failure. We found that there was a high risk of bias in six of the seven included studies. </p> <p>We found no difference in the rate of kidney failure between patients who received statins and those who did not. Two studies (195 patients) reported serum creatinine (a marker of kidney function) after the operation. We found that serum creatinine was lower in patients in the statin group (indicating better kidney function). Other conclusions were limited by the small number of studies. However, patients who received statins did not seem to need less dialysis. They did not have a higher rate of death in hospital and did not have an increased rate of adverse events. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010480-sec-0090" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010480-sec-0090"></div> <h3 class="title" id="CD010480-sec-0091">Implications for practice</h3> <section id="CD010480-sec-0091"> <p>When considering the five RCTs (467 participants) that reported the primary outcome of AKI, our analysis demonstrated no reduction in AKI incidence in the setting of preoperative statin therapy. Whilst postoperative SCr was significantly lower in those treated with statins preoperatively (compared to placebo), only two studies (195 participants) adequately reported this outcome and results were driven by the results of a single study. As such, there is significant uncertainty regarding the strength of this result, and we are unable to draw a definitive conclusion. Overall, no reduction in mortality or need for RRT was seen with statin treatment. Adverse events were poorly reported in most studies, and no significant differences seen in the only study that reported this outcome adequately. Overall, there was no evidence of improved kidney health outcomes or mortality associated with empirical statin therapy for adults undergoing surgery requiring cardiac bypass. </p> </section> <h3 class="title" id="CD010480-sec-0092">Implications for research</h3> <section id="CD010480-sec-0092"> <p>Although our analysis did not show any benefit of preoperative statin therapy in the reduction of AKI for cardiopulmonary bypass surgery, our conclusion was drawn from only small number of studies with limited number of patients in total. Most of the studies were designed to investigate the incidence of AKI as a secondary outcome. Moreover, the outcome definition varied among different studies. Therefore further larger studies with their main focus on perioperative kidney function are required in order to investigate any potential effect of preoperative statin therapy. It is also necessary for future studies to have a standardised definition of AKI, such as the AKIN or RIFLE consensus classification which would allow more meaningful comparisons to be made. </p> <p>Further research is also required to assess any potential benefit of different types of statin therapy and different dose regimens. As there are newer statin agents emerging in the market, more studies are required to explore any potential renoprotective benefit of such agents. Upcoming studies should also collect detailed data regarding adverse events associated with statin use, as this was lacking in most of the RCTs included in this review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010480-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010480-sec-0029"></div> <div class="table" id="CD010480-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Statin therapy compared with placebo for reduction in AKI after cardiac surgery with bypass</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: adults undergoing surgery requiring cardiac bypass</b> </p> <p><b>Settings: hospital inpatients</b> </p> <p><b>Intervention: statin treatment prior to cardiac bypass surgery</b> </p> <p><b>Comparison: placebo or no drug therapy</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo or no drug therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Statins</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute kidney injury</b> </p> <p>Follow‐up: ICU stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27/232 (11.6%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21/235 (8.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76 (0.46 to 1.28)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. High risk of bias in most studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serum creatinine</b> </p> <p>Follow‐up: first 72 h post‐operative</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine ranged across control groups from 77.6 to 106 µmol/L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine in intervention groups was on average 21 µmol/L lower</p> <p>(95% CI ‐31.09 to ‐11.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference, both studies have high risk of bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renal replacement therapy</b> </p> <p>Follow‐up: ICU stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5/124 (4.0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4/127 (3.1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.8 (0.23 to 2.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Only one study reported the need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> <p>Follow‐up: hospital stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0/189 (0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3/192 (1.6%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.86 (0.43 to 34.4)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>381 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Very low event rate. High risk of bias amongst studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: treatment duration</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8/70 (11.4%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9/70 (12.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.13 (1.47 to 2.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Only one study adequately reported adverse events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; OR: Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>ICU ‐ intensive care unit</p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010480-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010480-sec-0030"></div> <section id="CD010480-sec-0031"> <h3 class="title" id="CD010480-sec-0031">Description of the condition</h3> <p>AKI is a common complication of cardiac surgery; incidence ranges from 1% to 30% according to the definition used (<a href="./references#CD010480-bbs2-0081" title="ConlonPJ , Stafford‐SmithM , WhiteWD , NewmanMF , KingS , WinnMP , et al. Acute renal failure following cardiac surgery. Nephrology Dialysis Transplantation1999;14(5):1158‐62. [MEDLINE: 10344355] ">Conlon 1999</a>; <a href="./references#CD010480-bbs2-0099" title="MariscalcoG , LorussoR , DominiciC , RenzulliA , SalaA . Acute kidney injury: a relevant complication after cardiac surgery. Annals of Thoracic Surgery2011;92(4):1539‐47. [MEDLINE: 21872837] ">Mariscalco 2011</a>; <a href="./references#CD010480-bbs2-0103" title="OstermannME , TaubeD , MorganCJ , EvansTW . Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Medicine2000;26(5):565‐71. [MEDLINE: 10923731] ">Ostermann 2000</a>; <a href="./references#CD010480-bbs2-0111" title="ThakarCV , LiangosO , YaredJP , NelsonD , PiedmonteMR , HariacharS , et al. ARF after open‐heart surgery: Influence of gender and race. American Journal of Kidney Diseases2003;41(4):742‐51. [MEDLINE: 12666060] ">Thakar 2003</a>). Cardiac surgery‐associated AKI (csa‐AKI) has been shown to be independently associated with increased morbidity and mortality (<a href="./references#CD010480-bbs2-0077" title="ChertowGM , LazarusJM , ChristiansenCL , CookEF , HammermeisterKE , GroverF , et al. Preoperative renal risk stratification. Circulation1997;95(4):878‐84. [MEDLINE: 9054745] ">Chertow 1997</a>) and a more complicated course of hospital admission. AKI is associated with longer intensive care unit (ICU) stays and increased costs, especially when renal replacement therapy (RRT) is required (<a href="./references#CD010480-bbs2-0080" title="CocaSG , YusufB , ShlipakMG , GargAX , ParikhCR . Long‐term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta‐analysis. American Journal of Kidney Diseases2009;53(6):961‐73. [MEDLINE: 19346042] ">Coca 2009</a>; <a href="./references#CD010480-bbs2-0107" title="SrisawatN , LawsinL , UchinoS , BellomoR , KellumJA , BEST Kidney Investigators. Cost of acute renal replacement therapy in the intensive care unit: results from The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study. Critical Care2010;14(2):R46. [MEDLINE: 20346163] ">Srisawat 2010</a>; <a href="./references#CD010480-bbs2-0109" title="SwaminathanM , ShawAD , Phillips‐ButeBG , McGugan‐ClarkPL , ArcherLE , TalbertS , et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Critical Care Medicine2007;35(10):2286‐91. [MEDLINE: 17944016] ">Swaminathan 2007</a>). </p> <p>Cardiopulmonary bypass use has been identified as an important risk factor for occurrence of csa‐AKI (<a href="./references#CD010480-bbs2-0074" title="BoveT , CalabròMG , LandoniG , AlettiG , MarinoG , CrescenziG , et al. The incidence and risk of acute renal failure after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia2004;18(4):442‐5. [MEDLINE: 15365924] ">Bove 2004</a>; <a href="./references#CD010480-bbs2-0076" title="ChawlaLS , ZhaoY , LoughFC , SchroederE , SeneffMG , BrennanJM . Off‐pump versus on‐pump coronary artery bypass grafting outcomes stratified by preoperative renal function. Journal of the American Society of Nephrology2012;23(8):1389‐97. [MEDLINE: 22595302] ">Chawla 2012</a>; <a href="./references#CD010480-bbs2-0094" title="LamyA , DevereauxPJ , PrabhakaranD , TaggartDP , HuS , PaolassoE , et al. Off‐pump or on‐pump coronary‐artery bypass grafting at 30 days. New England Journal of Medicine2012;366(16):1489‐97. [MEDLINE: 22449296] ">Lamy 2012</a>), and morbidity and mortality has not changed over the last decade despite significant advances in bypass technology (<a href="./references#CD010480-bbs2-0109" title="SwaminathanM , ShawAD , Phillips‐ButeBG , McGugan‐ClarkPL , ArcherLE , TalbertS , et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Critical Care Medicine2007;35(10):2286‐91. [MEDLINE: 17944016] ">Swaminathan 2007</a>). Other risk factors for development of AKI post cardiopulmonary bypass include pre‐existing chronic kidney disease (CKD) (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0006" target="_blank">Chertow 1997</a>), older age (<a href="./references#CD010480-bbs2-0098" title="ManganoCM , DiamondstoneLS , RamsayJG , AggarwalA , HerskowitzA , ManganoDT . Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Annals of Internal Medicine1998;128(3):194‐203. [MEDLINE: 9454527] ">Mangano 1998</a>), female gender (<a href="./references#CD010480-bbs2-0070" title="AsimakopoulosG , KaragounisAP , ValenciaO , AlexanderN , HowladerM , SarsamMA , et al. Renal function after cardiac surgery off‐ versus on‐pump coronary artery bypass: analysis using the Cockroft‐Gault formula for estimating creatinine clearance. Annals of Thoracic Surgery2005;79(6):2024‐31. [MEDLINE: 15919303] ">Asimakopoulos 2005</a>), reduced left ventricular function (<a href="./references#CD010480-bbs2-0101" title="MistiaenW , VanCauwelaertP , MuylaertP , DeWormE . A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. Journal of Cardiovascular Surgery2009;50(2):233‐7. [MEDLINE: 18948862] ">Mistiaen 2009</a>), congestive heart failure (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0021" target="_blank">Mangano 1998</a>), diabetes mellitus (<a href="./references#CD010480-bbs2-0078" title="ChukwuemekaA , WeiselA , MagantiM , NetteAF , WijeysunderaDN , BeattieWS , et al. Renal dysfunction in high‐risk patients after on‐pump and off‐pump coronary artery bypass surgery: a propensity score analysis. Annals of Thoracic Surgery2005;80(6):2148‐53. [MEDLINE: 16305860] ">Chukwuemeka 2005</a>), peripheral vascular disease (<a href="./references#CD010480-bbs2-0078" title="ChukwuemekaA , WeiselA , MagantiM , NetteAF , WijeysunderaDN , BeattieWS , et al. Renal dysfunction in high‐risk patients after on‐pump and off‐pump coronary artery bypass surgery: a propensity score analysis. Annals of Thoracic Surgery2005;80(6):2148‐53. [MEDLINE: 16305860] ">Chukwuemeka 2005</a>), pre‐operative use of an intra‐aortic balloon pump (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0005" target="_blank">Bove 2004</a>), need for emergent surgery (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0005" target="_blank">Bove 2004</a>), pre‐existing anaemia (<a href="./references#CD010480-bbs2-0092" title="KarkoutiK , WijeysunderaDN , YauTM , CallumJL , ChengDC , CrowtherM , et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation2009;119(4):495‐502. [MEDLINE: 19153273] ">Karkouti 2009</a>), cardiopulmonary bypass time (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0005" target="_blank">Bove 2004</a>), duration of cross clamp time (<a href="./references#CD010480-bbs2-0101" title="MistiaenW , VanCauwelaertP , MuylaertP , DeWormE . A thousand pericardial valves in aortic position: risk factors for postoperative acute renal function impairment in elderly. Journal of Cardiovascular Surgery2009;50(2):233‐7. [MEDLINE: 18948862] ">Mistiaen 2009</a>) and requirement for vasopressor support (<a href="./references#CD010480-bbs2-0069" title="AroraP , RajagopalamS , RanjanR , KolliH , SinghM , VenutoR , et al. Preoperative use of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clinical Journal of the American Society of Nephrology: CJASN2008;3(5):1266‐73. [MEDLINE: 18667735] ">Arora 2008</a>). </p> <p>Although an overall decrease in renal blood flow has been shown to significantly contribute to the diminished glomerular filtration rate (GFR) observed in ischaemic kidney injury, decreased renal blood flow alone cannot account for the total reduction in GFR. Renal toxicity is also thought to be mediated by cardiopulmonary bypass triggered activation of bone marrow derived cells, endothelial cells and renal epithelial cells resulting in reactive oxygen species generation and release of inflammatory mediators (<a href="./references#CD010480-bbs2-0075" title="BoyleEMJr , PohlmanTH , JohnsonMC , VerrierED . Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Annals of Thoracic Surgery1997;63(1):277‐84. [MEDLINE: 8993292] ">Boyle 1997</a>). The adhesion of inflammatory cells to activated endothelium in peritubular capillaries of the outer medulla leads to medullary congestion and hypoxic injury to the proximal tubule. Pro‐inflammatory cytokines secreted by infiltrating and resident cells contribute to further tissue injury until inflammatory resolution and tubular epithelial proliferation occurs bringing a return to normal tissue function (<a href="./references#CD010480-bbs2-0083" title="DevarajanP . Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology2006;17(6):1503‐20. [MEDLINE: 16707563] ">Devarajan 2006</a>). </p> </section> <section id="CD010480-sec-0032"> <h3 class="title" id="CD010480-sec-0032">Description of the intervention</h3> <p>Statins competitively inhibit the enzyme 3‐hydroxy 3‐methylglutaryl CoA (HMG CoA) reductase which catalyses the rate limiting step in cholesterol synthesis (<a href="./references#CD010480-bbs2-0085" title="EndoA , KurodaM , TanzawaK . Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity. FEBS Letters1976;72(2):323‐6. [MEDLINE: 16386050] ">Endo 1976</a>). Since approval for clinical use in 1987 statins have been shown to reduce the progression of atherosclerosis, improve survival and reduce the risks of vascular death, non‐fatal myocardial infarction, stroke, and the need for coronary revascularisation across a wide range of cholesterol levels (<a href="./references#CD010480-bbs2-0071" title="BaigentC , KeechA , KearneyPM , BlackwellL , BuckG , PollicinoC , et al. Efficacy and safety of cholesterol‐lowering treatment: prospective meta‐analysis of data from 90,056 participants in 14 randomised trials of statins. [Erratum appears in Lancet. 2008 Jun 21;371(9630):2084], [Erratum appears in Lancet. 2005 Oct 15‐21;366(9494):1358]. Lancet2005;366(9493):1267‐78. [MEDLINE: 16214597] ">Baigent 2005</a>). </p> </section> <section id="CD010480-sec-0033"> <h3 class="title" id="CD010480-sec-0033">How the intervention might work</h3> <p>In addition to their lipid lowering actions, statins have been shown to exert anti‐inflammatory and pleiotropic effects (<a href="./references#CD010480-bbs2-0087" title="Haslinger‐LöfflerB . Multiple effects of HMG‐CoA reductase inhibitors (statins) besides their lipid‐lowering function. Kidney International2008;74(5):553‐5. [MEDLINE: 18709024] ">Haslinger‐Löffler 2008</a>). In experimental models of AKI (<a href="./references#CD010480-bbs2-0086" title="GuelerF , RongS , ParkJK , FiebelerA , MenneJ , ElgerM , et al. Postischemic acute renal failure is reduced by short‐term statin treatment in a rat model. Journal of the American Society of Nephrology2002;13(9):2288‐98. [MEDLINE: 12191973] ">Gueler 2002</a>; <a href="./references#CD010480-bbs2-0090" title="InmanSR , DavisNA , MazzoneME , OlsonKM , LukaszekVA , YoderKN . Simvastatin and L‐arginine preserve renal function after ischemia/reperfusion injury. American Journal of the Medical Sciences2005;329(1):13‐7. [MEDLINE: 15654174] ">Inman 2005</a>; <a href="./references#CD010480-bbs2-0112" title="YokotaN , O'DonnellM , DanielsF , Burne‐TaneyM , KeaneW , KasiskeB , et al. Protective effect of HMG‐CoA reductase inhibitor on experimental renal ischemia‐reperfusion injury. American Journal of Nephrology2003;23(1):13‐7. [MEDLINE: 12373076] ">Yokota 2003</a>), statins have been shown to preserve kidney function. Similarly, <a href="./references#CD010480-bbs2-0099" title="MariscalcoG , LorussoR , DominiciC , RenzulliA , SalaA . Acute kidney injury: a relevant complication after cardiac surgery. Annals of Thoracic Surgery2011;92(4):1539‐47. [MEDLINE: 21872837] ">Mariscalco 2011</a> suggested that statins could reduce postoperative leukocyte and endothelial activation and result in significantly lower postoperative pro‐inflammatory serum cytokine levels. </p> <p>There is some evidence that statin administration before percutaneous coronary interventions reduces periprocedural cardiovascular events. However, results are inconsistent when AKI (contrast‐induced nephropathy) was considered as an outcome (<a href="./references#CD010480-bbs2-0091" title="JoSH , KooBK , ParkJS , KangHJ , ChoYS , KimYJ , et al. Prevention of radiocontrast medium‐induced nephropathy using short‐term high‐dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial‐‐a randomized controlled study. American Heart Journal2008;155(3):499, e1‐8. [MEDLINE: 18294484] ">Jo 2008</a>; <a href="./references#CD010480-bbs2-0104" title="OzhanH , ErdenI , OrduS , AydinM , CaglarO , BasarC , et al. Efficacy of short‐term high‐dose atorvastatin for prevention of contrast‐induced nephropathy in patients undergoing coronary angiography. Angiology2010;61(7):711‐4. [MEDLINE: 20395226] ">Ozan 2010</a>; <a href="./references#CD010480-bbs2-0106" title="PattiG . Short‐term high‐dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. Journal of Cardiovascular Medicine2011;12(5):305‐8. [MEDLINE: 21451331] ">Patti 2008</a>). A recent meta‐analysis (<a href="./references#CD010480-bbs2-0095" title="LiY , LiuY , FuL , MeiC , DaiB . Efficacy of short‐term high‐dose statin in preventing contrast‐induced nephropathy: a meta‐analysis of seven randomized controlled trials. PLoS One2012;7(4):e34450. [MEDLINE: 22511942] ">Li 2012</a>) supported the use of statins to prevent contrast‐induced nephropathy but concluded that their use must be considered in the context of variable patient demographics. Although the pathophysiology of contrast‐induced nephropathy is not fully understood, inflammation and oxidative stress may play an important role similar to a postulated mechanism of kidney injury after cardiac bypass surgery. Only small RCTs have been published to date, and results among patients undergoing cardiac surgery are conflicting. </p> </section> <section id="CD010480-sec-0034"> <h3 class="title" id="CD010480-sec-0034">Why it is important to do this review</h3> <p>Current evidence consists of numerous observational studies and a few small RCTs. Large observational studies have generated conflicting results: some suggest that statin administration could be associated with lower csa‐AKI incidence (<a href="./references#CD010480-bbs2-0073" title="BillingsFT4th , PretoriusM , SiewED , YuC , BrownNJ . Early postoperative statin therapy is associated with a lower incidence of acute kidney injury after cardiac surgery. Journal of Cardiothoracic &amp; Vascular Anesthesia2010;24(6):913‐20. [MEDLINE: 20599398] ">Billings 2010</a>; <a href="./references#CD010480-bbs2-0079" title="ClarkLL , IkonomidisJS , CrawfordFAJr , CrumbleyA3rd , KratzJM , StroudMR , et al. Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8‐year retrospective cohort study. Journal of Thoracic &amp; Cardiovascular Surgery2006;131(3):679‐85. [MEDLINE: 16515923] ">Clark 2006</a>; <a href="./references#CD010480-bbs2-0110" title="TabataM , KhalpeyZ , PirundiniPA , ByrneML , CohnLH , RawnJD . Renoprotective effect of preoperative statins in coronary artery bypass grafting. American Journal of Cardiology2007;100(3):442‐4. [MEDLINE: 17659925] ">Tabata 2007</a>) but others have suggested no effect (<a href="./references#CD010480-bbs2-0068" title="AliIS , ButhKJ . Preoperative statin use and in‐hospital outcomes following heart surgery in patients with unstable angina. European Journal of Cardio‐Thoracic Surgery2005;27(6):1051‐6. [MEDLINE: 15896616] ">Ali 2005</a>; <a href="./references#CD010480-bbs2-0105" title="PanW , PintarT , AntonJ , LeeVV , VaughnWK , CollardCD . Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation2004;110(11 Suppl 1):II45‐9. [MEDLINE: 15364837] ">Pan 2004</a>). Given their retrospective nature, such studies are limited by selection bias and their conclusions must be considered with care. Several systematic reviews have evaluated the overall benefits of perioperative statins in cardiac surgery (<a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a>; <a href="./references#CD010480-bbs2-0097" title="LiakopoulosOJ , KuhnEW , SlottoschI , WassmerG , WahlersT . Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2] ">Liakopoulos 2012</a>); however, none have focused on AKI as a primary outcome. </p> <p>There is a considerable need for effective therapies that prevent AKI in this setting because kidney dysfunction after surgery results in significantly increased morbidity compared with patients who maintain normal kidney function (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009055/full#CD009055-bbs2-0016" target="_blank">Karkouti 2009</a>). In general, prevention of kidney reperfusion injury after cardiac bypass surgery involves correction of dehydration and minimising nephrotoxins. Therefore, evidence indicating that statins help to prevent kidney injury in this setting will help to address this therapeutic gap. Recent evidence (including among patients not requiring RRT following AKI) suggests that kidney injury is associated with increased long‐term mortality risk independent of residual kidney function, with risk proportionate to the severity of the kidney injury (<a href="./references#CD010480-bbs2-0093" title="LafranceJP , MillerDR . Acute kidney injury associates with increased long‐term mortality. Journal of the American Society of Nephrology2010;21(2):345‐52. [MEDLINE: 20019168] ">Lafrance 2010</a>). </p> <p>This review focused on AKI and procedures requiring cardiac bypass, except cardiac transplantation surgery and correction of congenital cardiac defects. All levels of kidney injury were included. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010480-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010480-sec-0035"></div> <p>This review aimed to look at the evidence supporting the benefits of perioperative statins for AKI prevention in hospitalised adults after surgery who require cardiac bypass. The main objectives were: </p> <p> <ol id="CD010480-list-0001"> <li> <p>To determine whether use of statins was associated with preventing AKI development</p> </li> <li> <p>To determine whether use of statins was associated with reductions in in‐hospital mortality </p> </li> <li> <p>To determine whether use of statins was associated with reduced need for RRT</p> </li> <li> <p>To determine any adverse effects associated with the use of statins.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010480-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010480-sec-0036"></div> <section id="CD010480-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010480-sec-0038"> <h4 class="title">Types of studies</h4> <p>All published RCTs that compared statin use with placebo or standard treatment given preoperatively to patients undergoing surgery who required cardiac bypass were eligible for inclusion. The dose, type or duration of statins used was not restricted. Case reports and non‐randomised studies were not eligible for inclusion. </p> </section> <section id="CD010480-sec-0039"> <h4 class="title">Types of participants</h4> <section id="CD010480-sec-0040"> <h5 class="title">Inclusion criteria</h5> <p>All adult patients (aged &gt; 18 years) undergoing surgery requiring cardiopulmonary bypass were included. Studies including children or mixed child and adult populations were excluded unless data were presented separately. Studies that included patients undergoing cardiac surgery who did not require cardiopulmonary bypass were excluded. </p> </section> <section id="CD010480-sec-0041"> <h5 class="title">Exclusion criteria</h5> <p> <ol id="CD010480-list-0002"> <li> <p>Patients on extracorporeal RRT before the initiation of the study</p> </li> <li> <p>Patients undergoing cardiac transplantation or corrective surgery for congenital heart disease </p> </li> <li> <p>Kidney transplant recipients.</p> </li> </ol> </p> </section> </section> <section id="CD010480-sec-0042"> <h4 class="title">Types of interventions</h4> <p>We considered studies that investigated the use of statin therapy for any given duration and dose prior to surgery in people requiring cardiac bypass compared with placebo, no drug therapy or standard clinical care. All statins were considered for inclusion, with a priori subgroup analysis defined. </p> </section> <section id="CD010480-sec-0043"> <h4 class="title">Types of outcome measures</h4> <section id="CD010480-sec-0044"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome is the incidence of AKI after cardiac surgery.</p> <p>AKI is defined using the AKIN or RIFLE classification wherever provided. The Acute Kidney Injury Network (AKIN) (<a href="./references#CD010480-bbs2-0100" title="MehtaRL , KellumJA , ShahSV , MolitorisBA , RoncoC , WarnockDG , et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care2007;11(2):R31. [MEDLINE: 17331245] ">Mehta 2007</a>) defines three stages of injury (1, 2 and 3) based on increasingly severe reductions of kidney function (Stage 1: increase in serum creatinine (SCr) ≥ 0.3 mg/dL, or 1.5‐ to 2‐fold increase from baseline; Stage 2: increase in SCr ≥ 150% to 200% from baseline; Stage 3: increase in SCr &gt; 3‐fold from baseline, &gt; 300% from baseline, ≥ 4.0 mg/dL, or initiation of RRT regardless of stage). The RIFLE criteria, proposed by the Acute Dialysis Quality Initiative group (<a href="./references#CD010480-bbs2-0072" title="BellomoR , RoncoC , KellumJA , MehtaRL , PalevskyP , Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care2004;8(4):R204‐12. [MEDLINE: 15312219] ">Bellomo 2004</a>) defines five levels of AKI (<b>R</b> isk, <b>I</b> njury, <b>F</b> ailure, <b>L</b> oss and <b>E</b>nd‐stage kidney disease) based on incremental reductions in kidney function. </p> <p>If AKI was not reported in the context of these criteria, efforts were made to classify patients. </p> </section> <section id="CD010480-sec-0045"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010480-list-0003"> <li> <p>SCr changes during the same hospitalisation</p> </li> <li> <p>In‐hospital mortality</p> </li> <li> <p>Need for RRT during the same hospitalisation</p> </li> <li> <p>Adverse effects attributed to the intervention (elevated liver enzymes, creatinine kinase levels, rhabdomyolysis or drug withdrawal). </p> </li> </ol> </p> </section> </section> </section> <section id="CD010480-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010480-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Renal Group's Specialised Register to 13 January 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. The Cochrane Renal Group’s Specialised Register contains studies identified from the following sources. </p> <p> <ol id="CD010480-list-0004"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of renal‐related journals and the proceedings of major renal conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected renal journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of the Cochrane Renal Group. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Renal Group</a>. </p> <p>See <a href="./appendices#CD010480-sec-0096">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD010480-sec-0048"> <h4 class="title">Searching other resources</h4> <p>Further potential studies were assessed through handsearching reference lists of nephrology textbooks, review articles and relevant studies. Letters were submitted seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </section> </section> <section id="CD010480-sec-0049"> <h3 class="title" id="CD010480-sec-0049">Data collection and analysis</h3> <section id="CD010480-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Literature search was performed using the predefined search strategy (<a href="./appendices#CD010480-sec-0096">Appendix 1</a>) to identify studies eligible for inclusion. The titles and abstracts were screened initially. Studies that potentially contained information relevant to the review were retained, whereas studies that did not meet the pre‐specified criteria were excluded. All potentially relevant studies were then uploaded to a reference management database. Each author independently reviewed the abstract or full text (where required) of the retained articles to assess suitability for inclusion in this review. Reasons for exclusion were noted. Cross checking was performed by at least one further author to determine the final eligibility for inclusion, and disagreements were arbitrated amongst all three authors until a consensus was reached. </p> </section> <section id="CD010480-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted independently by all three authors using a standardised data extraction form, which was designed by AS and initially piloted by all three authors. The information obtained from each included study was cross‐checked by at least one additional author. Disagreements were arbitrated between all three authors until a consensus was reached. Where more than one publication of a study existed, reports were grouped together and the most complete data set was included. Any discrepancy between published versions has been highlighted. Unclear data were clarified through correspondence with the study authors and any data obtained in this way were included in the review and analysis. Data extracted included study design, inclusion and exclusion criteria, patient numbers and characteristics. Treatment regimen and duration as well as duration of follow‐up were included. For outcomes of interest (AKI, SCr, mortality, need for RRT, adverse events), the raw data were extracted using mean, median and standard deviations for continuous outcomes, and event rate for dichotomous outcomes. Where data were collected at more than one time‐point, we extracted all data and analysed different time‐points for comparison. </p> </section> <section id="CD010480-sec-0052"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>All three authors independently performed the risk of bias assessment for between two to three of the included studies, with each assessment cross‐checked by a second author. Any disagreements were arbitrated between all three authors until a consensus was reached. Risk of bias was assessed using a risk of bias assessment tool (see <a href="./appendices#CD010480-sec-0097">Appendix 2</a>), and according to the standards of the Cochrane Collaboration (<a href="./references#CD010480-bbs2-0089" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The following items were assessed. </p> <p> <ul id="CD010480-list-0005"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study (detection bias)? </p> <ul id="CD010480-list-0006"> <li> <p>Participants and personnel</p> </li> <li> <p>Outcome assessors</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> <p>In each domain, studies were labelled as low, high or unclear risk of bias with consideration given to the presence or absence of sufficient information to make a determination. Reasons for assessment were documented (See <a href="./references#CD010480-sec-0105" title="">Characteristics of included studies</a>), and a risk of bias summary is presented. </p> </section> <section id="CD010480-sec-0053"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (e.g. proportion of AKI, need for RRT, mortality rates and number of adverse events), results are expressed as risk ratios (RR) with 95% confidence intervals (CI), calculated using the random effects model. A RR &lt; 1 favours statin treatment over control. As postoperative SCr is a continuous outcome it was first converted to standardised units (µmol/L) and the mean difference (MD) with 95% CI was subsequently used for comparisons. </p> </section> <section id="CD010480-sec-0054"> <h4 class="title">Unit of analysis issues</h4> <p>Studies with non‐standard designs, such as cross‐over studies and cluster‐randomised studies were not included in this review. </p> </section> <section id="CD010480-sec-0055"> <h4 class="title">Dealing with missing data</h4> <p>Any missing outcome data were requested from the corresponding author of the study. All the relevant information obtained via this method was included in this review. In one included study (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>), there was lack of information surrounding SCr levels which were graphically presented. After written correspondence, the authors of this study provided mean and standard deviation of the SCr level and blood urea nitrogen (BUN) preoperatively, and at 24 hours, 48 hours and 72 hours postoperatively. Data surrounding need for RRT and mortality data were also provided. An author from <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> was contacted for perioperative SCr data, which were also provided. No further missing outcome data were imputed for the purposes of this review. Given the universally short follow‐up periods of the included studies, loss to follow‐up was minimal. In one study that reported 15 patients dropped out (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), data within this study were analysed on intention‐to‐treat principle, followed by reanalysis on per‐protocol basis, in which no outcomes were materially affected. The intention‐to‐treat data from this study were used for the purposes of this review. In the only other study reporting significant drop outs (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>), only those completing the study were included in the analysis, and study data were used as reported. </p> </section> <section id="CD010480-sec-0056"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the heterogeneity between included studies using the Chi<sup>2</sup> test on N‐1 degrees of freedom with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> statistic (<a href="./references#CD010480-bbs2-0088" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). We considered statistical significance in heterogeneity surrounding calculation of the I<sup>2</sup>, although Chi<sup>2</sup> with alpha &lt; 0.05 was also considered. Based on the Cochrane Handbook (<a href="./references#CD010480-bbs2-0089" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), I<sup>2</sup> of 0% to 40% may not be important, I<sup>2</sup> of 30% to 60% may represent moderate heterogeneity, I<sup>2</sup> of 50% to 90% may represent substantial heterogeneity and I<sup>2</sup> of 75% to 100% may represent considerable heterogeneity. Visual inspection of forest plots provided added evidence of heterogeneity. </p> </section> <section id="CD010480-sec-0057"> <h4 class="title">Assessment of reporting biases</h4> <p>In order to detect any publication bias, electronic searching of web sites with current clinical study protocols was undertaken. Funnel plot analysis (<a href="./references#CD010480-bbs2-0108" title="SterneJA , EggerM , SmithGD . Systematic reviews in health care: investigating and dealing with publication and other biases in meta‐analysis. BMJ2001;327(7304):101‐5. [MEDLINE: 11451790] ">Sterne 2001</a>) was planned to further investigate, however there were insufficient number of included studies and this analysis was not feasible. We also assessed selective reporting of outcomes in the included studies. Language bias was minimized by not applying any language restrictions during the search strategy. </p> </section> <section id="CD010480-sec-0058"> <h4 class="title">Data synthesis</h4> <p>The data from the available studies were pooled using the random effects model (<a href="./references#CD010480-bbs2-0082" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. [MEDLINE: 3802833] ">DerSimonian 1986</a>), however the fixed effects model (<a href="./references#CD010480-bbs2-0084" title="EggerM , Davey SmithG , PhillipsAN . Meta‐analysis: Principles and procedures. BMJ1997;315(7121):1533‐7. [MEDLINE: 9432252] ">Egger 1997</a>) was also undertaken for comparison. The random effects model was used for the primary analysis as there is variability in the form, dose and duration of statin therapy used amongst studies of this nature, and some heterogeneity was expected. Before a pooled data analysis was performed for each outcome of interest, we assessed all the relevant studies to determine the eligibility of data comparison. We excluded pooled data analysis and only presented the result with narrative description when there were not sufficient comparable data available for a specific outcome. </p> </section> <section id="CD010480-sec-0059"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was used to explore possible sources of heterogeneity such as those amongst participants, treatments and study quality. Heterogeneity in patients could be related to age, preoperative renal pathology and other risk factors for renal reperfusion injury. Heterogeneity in treatments could be related to prior agent(s) used and the dose, duration and type of statin used. Despite small numbers of included studies, we investigated the potential differences through subgroup analysis according to type of statin used. </p> </section> <section id="CD010480-sec-0060"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses if there were sufficient studies identified, in order to explore the influence of the following factors on effect size. </p> <p> <ul id="CD010480-list-0007"> <li> <p>Repeating the analysis excluding unpublished studies</p> </li> <li> <p>Repeating the analysis taking account of risk of bias, as specified above</p> </li> <li> <p>Repeating the analysis excluding any very long or large studies to establish how much they dominate the results </p> </li> <li> <p>Repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), and country. </p> </li> </ul> </p> <p>Too few studies were identified that met the inclusion criteria for this review, therefore sensitivity analyses were not undertaken. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010480-sec-0061" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010480-sec-0061"></div> <section id="CD010480-sec-0062"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD010480-sec-0105" title="">Characteristics of included studies</a>; <a href="./references#CD010480-sec-0106" title="">Characteristics of excluded studies</a> </p> <section id="CD010480-sec-0063"> <h4 class="title">Results of the search</h4> <p>We identified 89 records from the Cochrane Renal Group's Specialised Register (<a href="#CD010480-fig-0001">Figure 1</a>); no studies were identified from searches of the reference lists of relevant review articles (<a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a>; <a href="./references#CD010480-bbs2-0102" title="MorganC , ZappitelliM , GillP . Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review. Critical Care2009;13(5):R165. [MEDLINE: 19840397] ">Morgan 2009</a>). After screening titles, abstracts and the full text, 53 studies (71 records) were excluded and two ongoing studies were identified (<a href="./references#CD010480-bbs2-0066" title="ZhouS . Anti‐inflammatory and renoprotective effect of pretreatment loading dose atorvastatin in CABG. www.clinicaltrials.gov/ct2/show/NCT01547455 (accessed 13 January 2015). ">NCT01547455</a>; <a href="./references#CD010480-bbs2-0067" title="BillingsFT4th , BallSK , RobertsLJ2nd , PretoriusM . Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response. Free Radical Biology &amp; Medicine2011;50(11):1480‐7. [MEDLINE: 21334433] ">STATIN AKI 2011</a>). Seven studies met our inclusion criteria (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>). </p> <div class="figure" id="CD010480-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010480-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Prior to publication of this review a final search of the Specialised Register identified five new potential studies and these will be assessed for inclusion in a future update of this review (<a href="./references#CD010480-bbs2-0061" title="deOliveiraMS , MartinsKB , CostaJRJr , AbizaidA , StadlerJ , MattosLA , et al. Impact on renal function of rosuvastatin preload prior to elective percutaneous coronary intervention in chronic statin users [Impacto na funcao renal de uma dose de reforco de rosuvastatina previa a intervencao coronaria percutanea eletiva nos pacientes em uso cronico de estatina]. Revista Brasileira de Cardiologia Invasiva2012;20(3):303‐8. [EMBASE: 2013021434] ">de Oliveira 2012</a>; <a href="./references#CD010480-bbs2-0062" title="HanS , LiXM , Mohammed AliLA , FuNK , JinDX , CongHL . Effect of short‐term different statins loading dose on renal function and CI‐AKI incidence in patients undergoing invasive coronary procedures. International Journal of Cardiology2013;168(5):5101‐3. [MEDLINE: 23972962] ">Han 2013</a>; <a href="./references#CD010480-bbs2-0063" title="LiuWJ , ZhangBC , GuoR , WeiYD , LiWM , XuYW . Renoprotective effect of alprostadil in combination with statins in patients with mild to moderate renal failure undergoing coronary angiography. Chinese Medical Journal2013;126(18):3475‐80. [MEDLINE: 24034093] ">Liu 2013</a>; <a href="./references#CD010480-bbs2-0064" title="BriguoriC , ViscontiG , FocaccioA , GoliaB , ChieffoA , CastelliA , et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. Journal of the American College of Cardiology2009;54(23):2157‐63. [MEDLINE: 19664895] QuintavalleC , FioreD , DeMiccoF , ViscontiG , FocaccioA , GoliaB , et al. Impact of a high loading dose of atorvastatin on contrast‐induced acute kidney injury. Circulation2012;126(25):3008‐16. [MEDLINE: 23147173] ">NAPLES II Study 2009</a>; <a href="./references#CD010480-bbs2-0065" title="KayaA , KurtM , TanbogaIH , IsikT , EkinciM , AksakalE , et al. Rosuvastatin versus atorvastatin to prevent contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention (ROSA‐cIN trial). Acta Cardiologica2013;68(5):489‐94. [MEDLINE: 24283110] ">ROSA‐cIN Trial 2013</a>). </p> </section> <section id="CD010480-sec-0064"> <h4 class="title">Included studies</h4> <p>The seven studies included in our analyses were all RCTs and included a treatment arm of statin and comparator arm of no drug treatment or placebo. The studies included had variable primary outcomes, however all included at least one of the pre‐specified outcomes of interest for this review. Authors were contacted to provide data for SCr and urine output and additional information for SCr was gained from two of the included studies. </p> <p>See <a href="./references#CD010480-sec-0105" title="">Characteristics of included studies</a> </p> <section id="CD010480-sec-0065"> <h5 class="title">Design</h5> <p>After evaluation, seven RCTs published between 1999 and 2012 were included in this review. All were published in English. </p> </section> <section id="CD010480-sec-0066"> <h5 class="title">Sample size</h5> <p>Sample size varied from 40 (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>) to 200 participants (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>) to provide data on a total of 662 adult patients undergoing cardiac surgery, of whom 334 received statin therapy and 328 received placebo or no drug therapy. </p> </section> <section id="CD010480-sec-0067"> <h5 class="title">Setting</h5> <p>Five of the seven studies were undertaken in European centres, and one each in China and Australia. All were undertaken in inpatient hospital settings with follow‐up limited to inpatient hospital stays. </p> </section> <section id="CD010480-sec-0068"> <h5 class="title">Participants</h5> <p>All studies evaluated adult inpatients undergoing cardiac bypass. One study exclusively enrolled patients undergoing non‐coronary artery surgery (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>) compared to the other included studies that predominantly evaluated those undergoing coronary artery bypass surgery. Most studies excluded those with baseline kidney impairment (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) although of note, there was no consensus amongst these studies on levels of kidney impairment that led to exclusion. </p> </section> <section id="CD010480-sec-0069"> <h5 class="title">Interventions</h5> <p>Three studies evaluated atorvastatin (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>), three evaluated simvastatin (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) and one study evaluated rosuvastatin (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>). All studies compared pre‐operative statin treatment to placebo or no drug treatment. Use of statins prior to enrolment was variable, with three studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>;<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a><a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) not reporting prior use. Two studies (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>) had a mandated statin‐free period of more than one year prior to enrolment, and two studies had much shorter statin‐free periods of a minimum 30 days (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>) and 24 hours (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) prior to enrolment. </p> <p>Doses of statin used varied; atorvastatin ranged from 20 mg/d (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>) to 40 mg/d (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), simvastatin was 20 mg/d (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) and rosuvastatin was 20 mg/d (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>). Of note, only <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a> titrated statin dose to lipid levels, with simvastatin increased to 40 mg two weeks prior to surgery if adequate lipid lowering had not been achieved. </p> <p>Duration of preoperative statin therapy was also variable between the studies, with periods ranging from commencement on the day of operation (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) through to four weeks preoperatively (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>). Three of the studies commenced therapy three weeks prior to surgery (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) and two studies commenced therapy between five to seven days preoperatively (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>). The period of postoperative statin therapy was not clarified in 5/7 studies (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). In two studies the statin was continued for three days postoperatively (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) and recommenced on day two postoperatively for ongoing therapy (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>). </p> </section> <section id="CD010480-sec-0070"> <h5 class="title">Outcomes</h5> <p>With the exception of <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> none of the studies listed AKI as a primary outcome. For our pre‐specified outcomes of interest, 5/7 studies reported AKI (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>), 3/7 studies reported SCr (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>), 2/7 studies reported need for RRT (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), 5/7 reported mortality (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>;<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>), and 2/7 studies reported adverse events (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). Standardisation of outcome reporting for the outcomes of AKI, SCr and adverse events was a significant issue. The definitions of AKI ranged from using the validated RIFLE criteria (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), to using a single SCr cut‐off (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>) or increase in SCr (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>) to providing no clarifying definition (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>). No conversion to AKIN criteria was able to be achieved. Units of measure of SCr were able to be freely converted to µmol/L, however time point reporting varied widely amongst studies. <a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a> reported SCr data at 24, 48 and 72 hour time points, while for <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a> the time‐point of SCr was unable to be clarified, although data collection was ceased at 48 hours. <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> reported only peak SCr values, which were taken one to five days postoperatively. Finally, adverse events were defined clearly in one study (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) as alanine transferase (ALT) &gt; 3 times the upper limit or normal (ULN), creatine kinase (CK) &gt; 5000 IU/L, or study drug being stopped by the treating clinician. <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a> reported only that no adverse events were experienced, without qualification. </p> </section> </section> <section id="CD010480-sec-0071"> <h4 class="title">Excluded studies</h4> <p>Overall, 53 studies were excluded after critical appraisal of title, abstract or full text (See <a href="./references#CD010480-sec-0106" title="">Characteristics of excluded studies</a>). One study did not fulfil the criteria for a RCT; 24 contained no outcome of interest, 25 were excluded as they did not use cardiac bypass in the procedure and three did not use statins as a comparator arm, or used a statin in both arms. </p> </section> </section> <section id="CD010480-sec-0072"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD010480-fig-0002">Figure 2</a> and <a href="#CD010480-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010480-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010480-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010480-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010480-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Overall, the study quality was variable, with high risk of bias assessed in at least one domain for 5/7 studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). Only <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> was considered truly to be at low risk of bias, with <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a> assessed as unclear risk of bias based on identification of potential selection bias. </p> <section id="CD010480-sec-0073"> <h4 class="title">Allocation</h4> <p>Only three of the studies were assessed as low risk, with adequate description of randomisation methods including the use of computer generated algorithms (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). The other four studies (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) made variable mention of randomisation, however they did not provide enough detailed information regarding actual randomisation procedures undertaken to determine risk of bias, and were therefore deemed to be unclear. </p> </section> <section id="CD010480-sec-0074"> <h4 class="title">Blinding</h4> <p>Whilst the mention of 'blinding' was made in the majority of studies, the methods by which this was achieved were not clearly described. Only two of the studies made mention of use of placebo and the methods undertaken to administer this (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). Despite this, the outcome measures of interest for this review (AKI, need for RRT, SCr, mortality and adverse events) are objective, and thus it was felt that whilst this represented poor reporting practices for the majority of the studies it did in fact constitute a low risk of bias for these outcome measures. </p> </section> <section id="CD010480-sec-0075"> <h4 class="title">Incomplete outcome data</h4> <p>Most studies reported no loss to follow‐up or incomplete outcome data. This is likely secondary to the short follow‐up period, with no long‐term follow‐up undertaken in any study. Two studies reported patient drop out, with incomplete data collection. One study (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) reported a number of patient drop‐outs (15), however study results were not affected when reanalysed on a per protocol basis, with the primary analysis remaining as intention to treat. The missing data were evenly spread across groups (statin (8); control (7)) and dropout was for comparable reasons. Given this transparency, it was felt that this represented low risk of bias. The second study (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>) reported that 19 patients were excluded from the analysis (statin (9), placebo (10)). The drop out was for comparable reasons, including liver dysfunction (statin (2), placebo (3)), and non‐completion not further defined (statin (4), placebo (6)). A further two patients in the statin group underwent surgery without cardiac bypass. Whilst these patients were excluded from the analysis, the dropout is even across groups and for comparable reasons, so again, was felt to represent low risk of bias. </p> </section> <section id="CD010480-sec-0076"> <h4 class="title">Selective reporting</h4> <p>All the studies reported the outcomes that were prespecified in their methods. However, 5/7 studies were felt to have high risk of reporting bias (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) as drug studies would be expected to report adverse events as outcome data and these studies failed to do so. <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> very clearly reported definitions of adverse events and event rate. <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a> did report that no adverse drug related events were seen, however failed to define what constituted an event. As such, this was determined to be unclear risk of bias as judgement was unable to be made. </p> </section> <section id="CD010480-sec-0077"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a> was industry funded, however made no mention of the role that this funding body played in the design and execution of the study or analysis of results, therefore risk of bias was deemed high. Two studies did not reporting funding and were deemed unclear (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>). No other potential sources of bias were identified. </p> </section> </section> <section id="CD010480-sec-0078"> <h3 class="title" id="CD010480-sec-0078">Effects of interventions</h3> <p>See: <a href="./full#CD010480-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>See <a href="./full#CD010480-tbl-0001">summary of findings Table for the main comparison</a>. Seven studies enrolling 662 participants were evaluated. Both fixed and random effects models were used in the initial analysis. No significant differences were found, therefore the summary estimates reported here were from the random effects models. Given the limited number of included studies, no sensitivity analysis was undertaken. </p> <section id="CD010480-sec-0079"> <h4 class="title">Postoperative AKI</h4> <p>Five studies (467 participants) reported postoperative AKI (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>). There was no significant difference between groups in preventing postoperative AKI (<a href="./references#CD010480-fig-0004" title="">Analysis 1.1</a> (5 studies, 467 participants): RR 0.76, 95% CI 0.46 to 1.28). There was no significant heterogeneity demonstrated (I<sup>2</sup> = 0%). Despite the limited number of studies, a subgroup analysis by statin class was performed. For those studies using atorvastatin no statistically significant difference was seen in postoperative AKI between groups (<a href="./references#CD010480-fig-0004" title="">Analysis 1.1</a>.1 (3 studies, 190 participants): RR 0.83, 95% CI 0.46 to 1.49). For the single studies assessing simvastatin and rosuvastatin, no differences were seen between the groups (<a href="./references#CD010480-fig-0004" title="">Analysis 1.1</a>.2; <a href="./references#CD010480-fig-0004" title="">Analysis 1.1</a>.3). Subclass differences were assessed, with a calculated I<sup>2</sup> of 34%, indicating a potential low level of variability amongst studies when considering result by statin subgroup. Whilst this may indicate different effects by statin (i.e. trends to benefit versus harm by class used), the low event rates overall and wide confidence intervals seen in conjunction with the low number of studies in each subgroup make it difficult to draw firm conclusions. </p> </section> <section id="CD010480-sec-0080"> <h4 class="title">Postoperative serum creatinine</h4> <p>Three studies (195 participants) reported postoperative SCr (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). Given differences in outcome reporting previously described, pooled analysis was only possible for two of these studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a> (195 participants). Statin treatment significantly decreased 24 hour postoperative SCr (<a href="./references#CD010480-fig-0005" title="">Analysis 1.2</a> (2 studies, 195 participants): MD ‐21.25 µmol/L, 95% CI ‐31.09 to ‐11.41; I<sup>2</sup> = 0%) with the result driven by differences seen in one study (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>) which received 85.7% of the weighting. As data were available at two time points for this study, analysis of the 48 hour SCr was also significantly decreased in the statin group (<a href="./references#CD010480-fig-0006" title="">Analysis 1.3</a> (2 studies, 195 participants): MD ‐20.97µmol/L, 95% CI ‐34.58 to ‐7.35; I<sup>2</sup> = 12%). Given that <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) collected data to a maximum of 48 hours, the 72 hour time point was not undertaken. </p> </section> <section id="CD010480-sec-0081"> <h4 class="title">Perioperative mortality</h4> <p>Mortality outcomes were reported in six studies (458 participants) (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). Given the universally short periods of follow‐up, low numbers of deaths were reported, all within the statin treatment arm of two studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). Despite the individual studies showing trends to favour placebo for this outcome, there was no statistically significant difference in mortality seen between groups in the pooled analysis (<a href="./references#CD010480-fig-0007" title="">Analysis 1.4</a> (6 studies, 458 participants): RR 3.86, 95% CI 0.43 to 34.40). There was no significant heterogeneity (I<sup>2</sup> = 0%) seen. With low event rates demonstrated confidence intervals were extremely wide, again making any interpretation of these results difficult. </p> </section> <section id="CD010480-sec-0082"> <h4 class="title">Need for postoperative renal replacement therapy</h4> <p>Need for postoperative RRT was reported in two studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). <a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a> reported no need for RRT in either group and there were near equal numbers needing RRT reported in <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>. There was no statistically significant difference between statin treatment and placebo (<a href="./references#CD010480-fig-0008" title="">Analysis 1.5</a> (2 studies, 251 participants): RR 0.80, 95% CI 0.23 to 2.81). There was no significant heterogeneity demonstrated (I<sup>2</sup> = 0%) </p> </section> <section id="CD010480-sec-0083"> <h4 class="title">Adverse events</h4> <p>Two studies (140 participants) reported adverse events however one study (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>) did not report adverse events related to statin use therefore no pooled analysis was undertaken. <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> reported rise in ALT x 3 upper limit of normal, creatine kinase rise &gt; 5000 IU/L and study drug cessation, the compared event rate between the groups did not reach statistical significance (P = 0.36, 0.36 and 1.0 respectively). </p> <p><a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> reported adverse events related to statin use. There was no significant difference in rise in ALT x 3 upper limit of normal (<a href="./references#CD010480-fig-0009" title="">Analysis 1.6</a>.1 (100 participants): RR 0.25, 95% CI 0.03 to 2.16), rise in creatine kinase &gt; 5000 IU/L (<a href="./references#CD010480-fig-0009" title="">Analysis 1.6</a>.2 (100 participants): RR 4.00, 95% CI 0.46 to 34.54) or study drug cessation (<a href="./references#CD010480-fig-0009" title="">Analysis 1.6</a>.3 (100 participants): RR 1.33, 95% CI 0.31 to 5.65) between atorvastatin and placebo. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010480-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010480-sec-0084"></div> <section id="CD010480-sec-0085"> <h3 class="title" id="CD010480-sec-0085">Summary of main results</h3> <p>After a search of the literature, seven RCTs with a total of 662 participants that addressed the use of statin intervention prior to cardiac bypass surgery and its effects on perioperative kidney injury were identified. All the included studies assessed our prespecified primary outcome of AKI, or one of our secondary outcomes of SCr, need for RRT or adverse events, although with the exception of one (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), all kidney outcomes were considered as secondary within the original studies. Three studies assessed atorvastatin (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>; 190 participants), three studies assessed simvastatin (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>; 272 participants) and one study used rosuvastatin (<a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>; 200 participants), with high variability in drug washout period (24 hours (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) to more than one year (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>)). Duration of pre‐operative drug therapy ranged from treatment commencing on the operative day (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) to four weeks preoperatively (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>). All studies were assessed as having a high risk of bias, with the exception of <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> which was assessed as having a low risk of bias in all five assessed domains. Study follow‐up was uniformly short, with all the studies collecting data to hospital discharge, and biochemical data collection ranging from 24 hours postoperatively (<a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>) up to seven days (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>). </p> <p>Overall for the outcome of AKI, the studies were variable in their results, however no individual study showed significant differences between statin treated and non‐drug treated groups. Our resultant meta‐analysis therefore showed no significant difference between the statin and comparator arms for incidence of AKI postoperatively (RR 0.76, 95% CI 0.46 to 1.28) (See <a href="./full#CD010480-tbl-0001">summary of findings Table for the main comparison</a>). The only finding of significance from all outcomes assessed was the difference in postoperative SCr between statin and placebo groups, an outcome which was measured in three studies (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>). Of these, significant variability in time‐point measurements allowed only two of the studies to be pooled for analysis. The third study (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>) showed no significant difference in maximal SCr reached between postoperative days 1 to 5 between the statin and placebo arms (rise of 28 µmol/L (16 to 55) versus 29 (16 to 54), P = 0.62). In the meta‐analysis (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>), the group treated with statin showed a mean postoperative SCr of 21.25 µmol/L lower than the non‐drug treated group (95% CI ‐31.09 to ‐11.41, P &lt; 0.0001). This result was largely driven through the strongly positive results in one study (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>), where SCr data at 24, 48 and 72 hour time‐points showed a significant benefit of statin therapy over no drug treatment (24 hour (MD ‐23.30 µmol/L, 95% CI ‐33.93 to ‐12.67, P &lt; 0.0001). For all other assessed outcomes (need for RRT, mortality, adverse events) no statistically or clinically significant difference was found between statin therapy and placebo or no therapy. Reliable conclusions were not able to be drawn from these analyses given the low numbers of studies reporting these outcomes, and concomitant low event rates.  </p> </section> <section id="CD010480-sec-0086"> <h3 class="title" id="CD010480-sec-0086">Overall completeness and applicability of evidence</h3> <p>There are significant limitations to this review. Given the lack of large, high‐quality RCTs, our meta‐analysis was limited to small heterogeneous studies. Studies were conducted in a range of settings, from Europe to China and Australia, with potentially important socio‐demographic and procedural differences between the centres. Similarly, despite recruiting populations of adult patients undergoing cardiac bypass, the included studies had different protocols and preoperative treatment duration, with inclusions ranging from exclusively statin naive patients (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>) to accepting different periods of drug washout, a setting unlikely to be seen in current clinical practice. For all studies but one (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>), the statin was administered before the operative day, but the pre‐operative treatment duration ranged from seven days (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>) to four weeks (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>). In addition, different statins were used as part of these protocols. Three studies used atorvastatin (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>), three used simvastatin (<a href="./references#CD010480-bbs2-0001" title="AlmansobMA , XuB , ZhouL , HuXX , ChenW , ChangFJ , et al. Simvastatin reduces myocardial injury undergoing noncoronary artery cardiac surgery: A randomized controlled trial. Arteriosclerosis Thrombosis &amp; Vascular Biology2012;32(9):2304‐13. [MEDLINE: 22796581] ">Almansob 2012</a>, <a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0007" title="TamayoE , AlonsoO , AlvarezFJ , CastrodezaJ , FlorezS , diStefanoS . Effects of simvastatin on acute‐phase protein levels after cardiac surgery [Efecto de la simvastatina en la concentracion de las proteinas de fase aguda despues de la cirugia cardiaca]. Medicina Clinica2008;130(20):773‐5. [MEDLINE: 18579030] TamayoE , AlvarezFJ , AlonsoO , BustamenteR , CastrodezaJ , SoriaS , et al. Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass. Journal of Cardiovascular Surgery2009;50(5):687‐94. [MEDLINE: 19741581] ">Tamayo 2009</a>) and <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a> used rosuvastatin. To take into account this potential for different effects across drug formulation, subgroup analyses were performed. However given the small number of patients, the power to detect a difference is very limited. The outcomes of interest for this review were largely secondary outcomes within the included studies, and therefore lack of consensus definition for AKI was an issue. Two studies (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>; <a href="./references#CD010480-bbs2-0004" title="MannacioVA , IorioD , DeAmicisV , DiLelloF , MusumeciF . Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. Journal of Thoracic &amp; Cardiovascular Surgery2008;136(6):1541‐8. [MEDLINE: 19114204] ">Mannacio 2008</a>) used SCr cut‐offs to dichotomise patients into AKI or no AKI (125 µmol/L for the first and 221µmol/L for the latter), while <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> used the currently recommended RIFLE criteria (<a href="./references#CD010480-bbs2-0072" title="BellomoR , RoncoC , KellumJA , MehtaRL , PalevskyP , Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care2004;8(4):R204‐12. [MEDLINE: 15312219] ">Bellomo 2004</a>), which are based both on a ratio of peak over baseline SCr level and urinary outputs. Finally, two studies (<a href="./references#CD010480-bbs2-0002" title="ChelloM , PattiG , CanduraD , MastrobuoniS , DiSciascioG , AgroF , et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Critical Care Medicine2006;34(3):660‐7. [MEDLINE: 16505650] ">Chello 2006</a>; <a href="./references#CD010480-bbs2-0006" title="SpadaccioC , PollariF , CasacalendaA , AlfanoG , GenoveseJ , CovinoE , et al. Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. Journal of Cardiovascular Pharmacology2010;55(1):30‐8. [MEDLINE: 19834333] ">Spadaccio 2010</a>) did not report their definition for AKI. </p> <p>Overall, only minimal information about post‐operative kidney function was available in these reports as AKI was only a secondary outcome in all but one study (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). The event numbers were low for many outcomes, and therefore power to detect differences between the groups may be limited. The safety of statin use in surgery requiring cardiac bypass was unable to be assessed as a secondary outcome due to a lack of reported data in the majority of included studies. </p> </section> <section id="CD010480-sec-0087"> <h3 class="title" id="CD010480-sec-0087">Quality of the evidence</h3> <p>With the exception of <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>, all of the studies were assessed as having high risk of bias in at least one domain. Drug studies would be expected to report clearly on the presence or absence of adverse events related to drug administration, however only <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a> adequately assessed and reported these events. In addition, most studies stated that randomisation was undertaken, without describing the methods of randomisation, allocation concealment and blinding of study participants. In cases where blinding was stated to have occurred, several studies did not describe use of a placebo, raising significant questions as to how blinding could possibly have been adequate. Despite this, outcome measures in this case were objective and therefore most studies were assessed as low risk of bias in this domain. Authors of the included studies were therefore not contacted to further clarify randomisation strategies. Compliance to newly prescribed medication may well be poor, which would potentially significantly affect the outcomes of the included studies. None of the included studies measured or addressed the issue of compliance directly, although one (<a href="./references#CD010480-bbs2-0003" title="ChristensonJT . Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease. American Journal of Cardiology2001;88(8):896‐9. [MEDLINE: 11676957] ChristensonJT . Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovascular Surgery2001;9(1):33‐43. [MEDLINE: 11137806] ChristensonJT . Preoperative lipid‐control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. European Journal of Cardio‐Thoracic Surgery1999;15(4):394‐9. [MEDLINE: 10371111] ">Christenson 1999</a>) did measure serial lipid profiles to assess preoperative change in the setting of statin use. Overall, given that 6/7 included studies had identified high risk of bias in at least one domain in addition to significant differences in methodology and outcome reporting practices, the quality of the evidence was assessed as low or very low across all outcome measures (See <a href="./full#CD010480-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD010480-sec-0088"> <h3 class="title" id="CD010480-sec-0088">Potential biases in the review process</h3> <p>We believe that all relevant studies were identified. A thorough search strategy was devised and all major databases were searched for relevant studies, with no language restrictions applied. All three authors assessed the studies for inclusion in the review and the risk of bias, with discrepancy discussed between the three authors. The biggest limitation of the review process was that not all studies reported the outcome of interest or reported in a different fashion. This is related to the lack of thoroughly accepted definition for AKI. Despite attempting to obtain additional data, we were not able to obtain sufficient data to adequately classify all patients according to the RIFLE (<a href="./references#CD010480-bbs2-0072" title="BellomoR , RoncoC , KellumJA , MehtaRL , PalevskyP , Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care2004;8(4):R204‐12. [MEDLINE: 15312219] ">Bellomo 2004</a>) or AKIN (<a href="./references#CD010480-bbs2-0100" title="MehtaRL , KellumJA , ShahSV , MolitorisBA , RoncoC , WarnockDG , et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care2007;11(2):R31. [MEDLINE: 17331245] ">Mehta 2007</a>) classification, and therefore our primary outcome (AKI) was considered as a dichotomous outcome rather than a stratified outcome based on reporting in the included studies. We did not include the results of unpublished studies. Studies with both positive and negative results were identified, making the possibility of publication bias less likely. No sensitivity analysis was able to be undertaken given the small number of studies eligible for inclusion in this review. </p> </section> <section id="CD010480-sec-0089"> <h3 class="title" id="CD010480-sec-0089">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, this is the first completed review that assesses the impact of preoperative statin use for surgery requiring cardiac bypass on the incidence of postoperative AKI. However, there have been systematic reviews that examined multiple clinical outcomes with the use of preoperative statin therapy after cardiac surgery. A systematic review with meta‐analysis (<a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a>) included more than 30,000 participants. It was shown that statin therapy had no effect on postoperative kidney failure (OR 0.78, 95% CI 0.46 to 1.31). This was in agreement with our findings. However, it reported an incidence of 4.1% kidney failure in a total of 6408 patients. This was much lower than our incidence of 10.3% AKI out of total of 467 patients. The discrepancy could be due to the fact that the majority of studies included in <a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a> were retrospective observational studies (only two small RCTs out of five studies), whereas this review included five RCTs for this particular analysis. There was also significant heterogeneity observed in <a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a> (P = 0.05; I<sup>2</sup> = 58.3%). </p> <p>In a more recent Cochrane review performed by the same author (<a href="./references#CD010480-bbs2-0097" title="LiakopoulosOJ , KuhnEW , SlottoschI , WassmerG , WahlersT . Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD008493.pub2] ">Liakopoulos 2012</a>), four studies reported the incidence of kidney failure in a total of 367 participants. The incidence of kidney failure was 3.2% in the statin group compared to 7.1% in the control group. This Cochrane analysis showed that statin treatment did not lead to a significant reduction of the odds of kidney failure (OR 0.41, 95% CI 0.15 to 1.12; P = 0,08). Our analysis also did not show any statistically significant difference between the two groups (RR 0.76; 95% CI: 0.46 to 1.28). A significant difference between our analysis and the previous Cochrane review related to inclusion in this review of a recent RCT reporting the outcome of AKI (<a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>). It was a well‐designed study with low risk of bias and it carried an important weight in the pooled analysis. In <a href="./references#CD010480-bbs2-0005" title="ProwleJR , CalzavaccaP , LicariE , LigaboEV , EcheverriJE , HaaseM , et al. Pilot double‐blind, randomized controlled trial of short‐term atorvastatin for prevention of acute kidney injury after cardiac surgery. Nephrology2012;17(3):215‐24. [MEDLINE: 22117606] ProwleJR , LicariE , CalzavaccaP , LigaboEV , EcheverriJE , HasseM , et al. Peri‐operative statin therapy does not alter the incidence of acute kidney injury after cardiopulmonary bypass: CREAT, the cardiopulmonary bypass, renal injury and atorvastatin trial. clinicaltrials.gov NCT00910221 [abstract]. Intensive Care Medicine2010;36:S88. [EMBASE: 70290230] ">Prowle 2012</a>, there were 13/50 patients with AKI in the statin group compared to 16/50 in the placebo group, (RR 0.81, 95% CI 0.44 to 1.51). This result would have likely attenuated the statistical trend observed in <a href="./references#CD010480-bbs2-0096" title="LiakopoulosOJ , ChoiYH , HaldenwangPL , StrauchJ , WittwerT , DörgeH , et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta‐analysis of over 30,000 patients. European Heart Journal2008;29(12):1548‐59. [MEDLINE: 18506053] ">Liakopoulos 2008</a>. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010480-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010480-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010480-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010480-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 1 Acute kidney injury." data-id="CD010480-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 1 Acute kidney injury.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 2 Serum creatinine: 24 h postoperatively." data-id="CD010480-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 2 Serum creatinine: 24 h postoperatively. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 3 Serum creatinine: 48 h postoperatively." data-id="CD010480-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 3 Serum creatinine: 48 h postoperatively. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 4 Mortality." data-id="CD010480-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 4 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 5 Renal replacement therapy." data-id="CD010480-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 5 Renal replacement therapy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010480-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/urn:x-wiley:14651858:media:CD010480:CD010480-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_t/tCD010480-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Statins versus placebo/no treatment, Outcome 6 Adverse events." data-id="CD010480-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Statins versus placebo/no treatment, Outcome 6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/media/CDSR/CD010480/image_n/nCD010480-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010480-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Statin therapy compared with placebo for reduction in AKI after cardiac surgery with bypass</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: adults undergoing surgery requiring cardiac bypass</b> </p> <p><b>Settings: hospital inpatients</b> </p> <p><b>Intervention: statin treatment prior to cardiac bypass surgery</b> </p> <p><b>Comparison: placebo or no drug therapy</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo or no drug therapy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Statins</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Acute kidney injury</b> </p> <p>Follow‐up: ICU stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>27/232 (11.6%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21/235 (8.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76 (0.46 to 1.28)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. High risk of bias in most studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Serum creatinine</b> </p> <p>Follow‐up: first 72 h post‐operative</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine ranged across control groups from 77.6 to 106 µmol/L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean serum creatinine in intervention groups was on average 21 µmol/L lower</p> <p>(95% CI ‐31.09 to ‐11.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Significant difference, both studies have high risk of bias</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renal replacement therapy</b> </p> <p>Follow‐up: ICU stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5/124 (4.0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4/127 (3.1%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.8 (0.23 to 2.81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>251 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Only one study reported the need for renal replacement therapy </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> </p> <p>Follow‐up: hospital stay</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0/189 (0%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3/192 (1.6%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.86 (0.43 to 34.4)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>381 (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Very low event rate. High risk of bias amongst studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: treatment duration</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>8/70 (11.4%)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9/70 (12.9%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.13 (1.47 to 2.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>140 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant difference. Only one study adequately reported adverse events</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; OR: Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>ICU ‐ intensive care unit</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/full#CD010480-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010480-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Statins versus placebo/no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Acute kidney injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.46, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Atorvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.46, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Simvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.10, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Rosuvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.32, 28.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Serum creatinine: 24 h postoperatively <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.25 [‐31.09, ‐11.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Simvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.25 [‐31.09, ‐11.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Serum creatinine: 48 h postoperatively <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.97 [‐34.58, ‐7.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Simvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐20.97 [‐34.58, ‐7.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [0.43, 34.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Atorvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.00 [0.25, 101.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Simvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 69.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Renal replacement therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Atorvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.8 [0.23, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Simvastatin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 ALT x 3 ULN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Creatinine kinase &gt; 5000 IU/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Study drug cessation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Statins versus placebo/no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010480.pub2/references#CD010480-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010480.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010480-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010480-note-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010480-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ru#CD010480-note-0001">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010480-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010480\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010480\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010480\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010480\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010480\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=BqmVIxTs&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010480.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010480.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010480.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010480.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010480.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740725175211"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010480.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740725175215"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010480.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e74d28a721be5',t:'MTc0MDcyNTE3NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 